Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia
The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) and show that rare variants affecting the nuclear- and mitochondrially-encoded complex I genes show near-mutual...
Saved in:
Published in | Nature communications Vol. 13; no. 1; p. 2614 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
12.05.2022
Nature Publishing Group Nature Portfolio |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) and show that rare variants affecting the nuclear- and mitochondrially-encoded complex I genes show near-mutual exclusivity with somatic driver mutations affecting isocitrate dehydrogenase 1 (
IDH1
), but not
IDH2
suggesting a unique epistatic relationship. Whereas AML cells with rare complex I variants or mutations in
IDH1
or
IDH2
all display attenuated mitochondrial respiration, heightened sensitivity to complex I inhibitors including the clinical-grade inhibitor, IACS-010759, is observed only for
IDH1
-mutant AML. Furthermore,
IDH1
mutant blasts that are resistant to the IDH1-mutant inhibitor, ivosidenib, retain sensitivity to complex I inhibition. We propose that the
IDH1
mutation limits the flexibility for citrate utilization in the presence of impaired complex I activity to a degree that is not apparent in
IDH2
mutant cells, exposing a mutation-specific metabolic vulnerability. This reduced metabolic plasticity explains the epistatic relationship between the germline complex I variants and oncogenic
IDH1
mutation underscoring the utility of genomic data in revealing metabolic vulnerabilities with implications for therapy.
Mitochondrial metabolism has been associated with tumourigenesis in acute myeloid leukaemia (AML) and currently considered as a potential therapeutic target. Here, the authors show, in patients with AML, that germline mutations in mitochondrial complex I are mutually exclusive with somatic mutations in the metabolic enzyme IDH1, and find IDH1 mutant cells have increased sensitivity to complex I inhibitors. |
---|---|
AbstractList | The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) and show that rare variants affecting the nuclear- and mitochondrially-encoded complex I genes show near-mutual exclusivity with somatic driver mutations affecting isocitrate dehydrogenase 1 (
IDH1
), but not
IDH2
suggesting a unique epistatic relationship. Whereas AML cells with rare complex I variants or mutations in
IDH1
or
IDH2
all display attenuated mitochondrial respiration, heightened sensitivity to complex I inhibitors including the clinical-grade inhibitor, IACS-010759, is observed only for
IDH1
-mutant AML. Furthermore,
IDH1
mutant blasts that are resistant to the IDH1-mutant inhibitor, ivosidenib, retain sensitivity to complex I inhibition. We propose that the
IDH1
mutation limits the flexibility for citrate utilization in the presence of impaired complex I activity to a degree that is not apparent in
IDH2
mutant cells, exposing a mutation-specific metabolic vulnerability. This reduced metabolic plasticity explains the epistatic relationship between the germline complex I variants and oncogenic
IDH1
mutation underscoring the utility of genomic data in revealing metabolic vulnerabilities with implications for therapy.
Mitochondrial metabolism has been associated with tumourigenesis in acute myeloid leukaemia (AML) and currently considered as a potential therapeutic target. Here, the authors show, in patients with AML, that germline mutations in mitochondrial complex I are mutually exclusive with somatic mutations in the metabolic enzyme IDH1, and find IDH1 mutant cells have increased sensitivity to complex I inhibitors. The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) and show that rare variants affecting the nuclear- and mitochondrially-encoded complex I genes show near-mutual exclusivity with somatic driver mutations affecting isocitrate dehydrogenase 1 ( IDH1 ), but not IDH2 suggesting a unique epistatic relationship. Whereas AML cells with rare complex I variants or mutations in IDH1 or IDH2 all display attenuated mitochondrial respiration, heightened sensitivity to complex I inhibitors including the clinical-grade inhibitor, IACS-010759, is observed only for IDH1 -mutant AML. Furthermore, IDH1 mutant blasts that are resistant to the IDH1-mutant inhibitor, ivosidenib, retain sensitivity to complex I inhibition. We propose that the IDH1 mutation limits the flexibility for citrate utilization in the presence of impaired complex I activity to a degree that is not apparent in IDH2 mutant cells, exposing a mutation-specific metabolic vulnerability. This reduced metabolic plasticity explains the epistatic relationship between the germline complex I variants and oncogenic IDH1 mutation underscoring the utility of genomic data in revealing metabolic vulnerabilities with implications for therapy. The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) and show that rare variants affecting the nuclear- and mitochondrially-encoded complex I genes show near-mutual exclusivity with somatic driver mutations affecting isocitrate dehydrogenase 1 (IDH1), but not IDH2 suggesting a unique epistatic relationship. Whereas AML cells with rare complex I variants or mutations in IDH1 or IDH2 all display attenuated mitochondrial respiration, heightened sensitivity to complex I inhibitors including the clinical-grade inhibitor, IACS-010759, is observed only for IDH1-mutant AML. Furthermore, IDH1 mutant blasts that are resistant to the IDH1-mutant inhibitor, ivosidenib, retain sensitivity to complex I inhibition. We propose that the IDH1 mutation limits the flexibility for citrate utilization in the presence of impaired complex I activity to a degree that is not apparent in IDH2 mutant cells, exposing a mutation-specific metabolic vulnerability. This reduced metabolic plasticity explains the epistatic relationship between the germline complex I variants and oncogenic IDH1 mutation underscoring the utility of genomic data in revealing metabolic vulnerabilities with implications for therapy. Mitochondrial metabolism has been associated with tumourigenesis in acute myeloid leukaemia (AML) and currently considered as a potential therapeutic target. Here, the authors show, in patients with AML, that germline mutations in mitochondrial complex I are mutually exclusive with somatic mutations in the metabolic enzyme IDH1, and find IDH1 mutant cells have increased sensitivity to complex I inhibitors. The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult acute myeloid leukaemia (AML) and show that rare variants affecting the nuclear- and mitochondrially-encoded complex I genes show near-mutual exclusivity with somatic driver mutations affecting isocitrate dehydrogenase 1 (IDH1), but not IDH2 suggesting a unique epistatic relationship. Whereas AML cells with rare complex I variants or mutations in IDH1 or IDH2 all display attenuated mitochondrial respiration, heightened sensitivity to complex I inhibitors including the clinical-grade inhibitor, IACS-010759, is observed only for IDH1-mutant AML. Furthermore, IDH1 mutant blasts that are resistant to the IDH1-mutant inhibitor, ivosidenib, retain sensitivity to complex I inhibition. We propose that the IDH1 mutation limits the flexibility for citrate utilization in the presence of impaired complex I activity to a degree that is not apparent in IDH2 mutant cells, exposing a mutation-specific metabolic vulnerability. This reduced metabolic plasticity explains the epistatic relationship between the germline complex I variants and oncogenic IDH1 mutation underscoring the utility of genomic data in revealing metabolic vulnerabilities with implications for therapy.Mitochondrial metabolism has been associated with tumourigenesis in acute myeloid leukaemia (AML) and currently considered as a potential therapeutic target. Here, the authors show, in patients with AML, that germline mutations in mitochondrial complex I are mutually exclusive with somatic mutations in the metabolic enzyme IDH1, and find IDH1 mutant cells have increased sensitivity to complex I inhibitors. |
ArticleNumber | 2614 |
Author | Brown, Anna L. Pitson, Stuart Gonda, Thomas J. Bassal, Mahmoud A. Majeti, Ravindra Casolari, Debora A. Kaur, Satinder Lewis, Ian D. D’Andrea, Richard J. Roessner, Ute Ross, David M. Toubia, John Maung, Kyaw Ze Ya Iarossi, Diana G. Powell, Jason Robinson, Nirmal Benard, Brooks A. Thompson-Peach, Chloe Natera, Siria Thomas, Daniel Samaraweera, Saumya E. Lim, Kelly Bailey, Sheree Leo, Paul Nguyen, Tran Tenen, Daniel G. Pagani, Ilaria S. |
Author_xml | – sequence: 1 givenname: Mahmoud A. orcidid: 0000-0003-4322-2968 surname: Bassal fullname: Bassal, Mahmoud A. organization: Harvard Stem Cell Institute, Harvard Medical School, Cancer Science Institute of Singapore, National University of Singapore – sequence: 2 givenname: Saumya E. orcidid: 0000-0002-9619-0624 surname: Samaraweera fullname: Samaraweera, Saumya E. organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 3 givenname: Kelly orcidid: 0000-0003-4606-7588 surname: Lim fullname: Lim, Kelly organization: Discipline of Medicine, University of Adelaide – sequence: 4 givenname: Brooks A. orcidid: 0000-0001-7154-744X surname: Benard fullname: Benard, Brooks A. organization: Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University – sequence: 5 givenname: Sheree orcidid: 0000-0001-6690-5476 surname: Bailey fullname: Bailey, Sheree organization: Clinical and Health Sciences, University of South Australia – sequence: 6 givenname: Satinder surname: Kaur fullname: Kaur, Satinder organization: Discipline of Medicine, University of Adelaide – sequence: 7 givenname: Paul surname: Leo fullname: Leo, Paul organization: Diamantina Institute, Translational Research Institute – sequence: 8 givenname: John orcidid: 0000-0002-5135-6504 surname: Toubia fullname: Toubia, John organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 9 givenname: Chloe orcidid: 0000-0001-7172-3183 surname: Thompson-Peach fullname: Thompson-Peach, Chloe organization: Discipline of Medicine, University of Adelaide – sequence: 10 givenname: Tran surname: Nguyen fullname: Nguyen, Tran organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 11 givenname: Kyaw Ze Ya surname: Maung fullname: Maung, Kyaw Ze Ya organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 12 givenname: Debora A. orcidid: 0000-0001-5072-0880 surname: Casolari fullname: Casolari, Debora A. organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 13 givenname: Diana G. surname: Iarossi fullname: Iarossi, Diana G. organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 14 givenname: Ilaria S. surname: Pagani fullname: Pagani, Ilaria S. organization: Precision Medicine Theme, South Australian Health and Medical Research Institute – sequence: 15 givenname: Jason surname: Powell fullname: Powell, Jason organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 16 givenname: Stuart orcidid: 0000-0002-9527-2740 surname: Pitson fullname: Pitson, Stuart organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 17 givenname: Siria surname: Natera fullname: Natera, Siria organization: Metabolomics Australia, The University of Melbourne – sequence: 18 givenname: Ute orcidid: 0000-0002-6482-2615 surname: Roessner fullname: Roessner, Ute organization: Metabolomics Australia, The University of Melbourne – sequence: 19 givenname: Ian D. surname: Lewis fullname: Lewis, Ian D. organization: Adelaide Oncology & Haematology – sequence: 20 givenname: Anna L. orcidid: 0000-0002-9023-0138 surname: Brown fullname: Brown, Anna L. organization: Centre for Cancer Biology, University of South Australia and SA Pathology, Clinical and Health Sciences, University of South Australia, Department of Genetics and Molecular Pathology, SA Pathology – sequence: 21 givenname: Daniel G. surname: Tenen fullname: Tenen, Daniel G. organization: Harvard Stem Cell Institute, Harvard Medical School, Cancer Science Institute of Singapore, National University of Singapore – sequence: 22 givenname: Nirmal orcidid: 0000-0002-7361-9491 surname: Robinson fullname: Robinson, Nirmal organization: Centre for Cancer Biology, University of South Australia and SA Pathology – sequence: 23 givenname: David M. surname: Ross fullname: Ross, David M. organization: Centre for Cancer Biology, University of South Australia and SA Pathology, Discipline of Medicine, University of Adelaide, Precision Medicine Theme, South Australian Health and Medical Research Institute, Department of Clinical Haematology, Royal Adelaide Hospital – sequence: 24 givenname: Ravindra orcidid: 0000-0002-5814-0984 surname: Majeti fullname: Majeti, Ravindra organization: Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University – sequence: 25 givenname: Thomas J. surname: Gonda fullname: Gonda, Thomas J. organization: Clinical and Health Sciences, University of South Australia, School of Pharmacy, University of Queensland – sequence: 26 givenname: Daniel orcidid: 0000-0002-0837-1231 surname: Thomas fullname: Thomas, Daniel organization: Discipline of Medicine, University of Adelaide, Hematology Division, Department of Medicine, Stanford Cancer Institute, Institute for Stem Cell and Regenerative Medicine, Stanford University, Precision Medicine Theme, South Australian Health and Medical Research Institute – sequence: 27 givenname: Richard J. orcidid: 0000-0002-4915-4612 surname: D’Andrea fullname: D’Andrea, Richard J. email: Richard.DAndrea@unisa.edu.au organization: Centre for Cancer Biology, University of South Australia and SA Pathology |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/35551192$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1v1DAQhiNUREvpH-CAInHhEvBXHPuChAq0K1XiAmfLsSdbL4692E7F3vjpeLultByw5A_NvH7GHr3Pm6MQAzTNS4zeYkTFu8ww40OHCOloXWgnnzQnBDHc4YHQowfn4-Ys5w2qg0osGHvWHNO-7zGW5KT5dQFp9i5AOy9FFxdDbl1oZ1eiuY7BJqd9a-K89fCzXbUJbqAG1hCgONPqYNui0xqKHj20N4sPkPTovCu7PWb18RJ3e3AorTZLqVV24KOzrYflu4bZ6RfN00n7DGd3-2nz7fOnr-eX3dWXi9X5h6vO9AyVbuKSS6slH0U_IhBCTLwnTNdeWBgnCoIyQTg2RkJdLaUwDJYSOjHT817S02Z14NqoN2qb3KzTTkXt1G0gprXSqf7JgxJIymEiSEimmeF6RNIyJLDg1EpsobLeH1jbZZzBGgglaf8I-jgT3LVaxxslkRR1VsCbO0CKPxbIRc0uG_BeB4hLVoRzNgiGMKvS1_9IN3FJobZqr6KY9pwMVUUOKpNizgmm-8dgpPZ-UQe_qGoVdesXtX_Fq4ffuL_yxx1VQA-CXFNhDelv7f9gfwOEQ84L |
CitedBy_id | crossref_primary_10_3390_ijms232415724 crossref_primary_10_1186_s40364_024_00600_1 crossref_primary_10_3390_biom13060944 crossref_primary_10_3390_cancers15184476 crossref_primary_10_1016_j_dnarep_2024_103700 crossref_primary_10_3390_molecules27248754 crossref_primary_10_1042_BST20230017 crossref_primary_10_1158_2159_8290_CD_21_0218 crossref_primary_10_1158_2159_8290_CD_22_1325 |
Cites_doi | 10.1016/j.jchromb.2015.07.002 10.3389/fonc.2021.686765 10.1182/blood.2019002140 10.1073/pnas.1324297111 10.1016/j.celrep.2017.12.050 10.1038/s41586-021-03819-2 10.1038/s41556-018-0118-z 10.1038/s41598-018-31489-0 10.1016/j.cell.2017.07.050 10.1038/nmeth.3213 10.1074/jbc.RA120.013366 10.1085/jgp.8.6.519 10.1016/j.cmet.2020.08.008 10.1002/gcc.22750 10.1016/j.ccell.2018.10.005 10.1016/j.bbcan.2019.188332 10.1038/s42255-019-0043-x 10.1038/ng0597-93 10.1016/j.beha.2015.10.016 10.1038/s41586-018-0623-z 10.1073/pnas.0506580102 10.1016/j.cell.2015.07.016 10.3389/fonc.2021.639387 10.1126/science.1234769 10.1182/blood.2019003988 10.1038/s41408-018-0090-7 10.1182/bloodadvances.2020001503 10.1038/s41388-017-0077-z 10.1093/bib/bbs017 10.1158/0008-5472.CAN-18-2220 10.1093/bioinformatics/btp616 10.1038/s41467-020-16423-1 10.1007/978-1-4939-7819-9_15 10.1038/nature12040 10.1158/1535-7163.MCT-19-0103 10.1056/NEJMoa1301689 10.1126/scitranslmed.3004315 10.1038/s41586-020-1969-6 10.1016/j.bbabio.2008.05.001 10.1038/s41591-018-0052-4 10.1016/j.ccr.2010.01.020 10.1038/s41568-020-0260-3 10.1007/978-1-4939-3578-9_19 10.1042/bst0210998 10.1093/bioinformatics/btx094 10.1093/bioinformatics/btw462 10.1158/1078-0432.CCR-13-1333 10.1016/j.stem.2015.08.008 10.1038/s41556-018-0125-0 10.1056/NEJMoa1716984 10.1093/hmg/ddr395 10.1016/j.cell.2015.07.017 10.1038/s41467-019-09352-1 10.1073/pnas.1211502109 10.1182/blood-2015-07-655860 10.1038/s41586-020-2475-6 10.1016/j.ccell.2019.06.003 10.1136/bmjopen-2016-014961 10.1158/2159-8290.CD-17-0476 10.1158/0008-5472.CAN-14-0772-T 10.1158/2159-8290.CD-17-0399 10.1073/pnas.1913633117 10.1038/nm.3788 10.1016/j.cmet.2020.07.009 10.1096/fj.201800547R 10.1038/s41375-021-01416-w 10.1126/scitranslmed.aav0936 10.1182/bloodadvances.2020003661 10.1038/s41588-021-00868-1 10.7554/eLife.45105 10.1126/scitranslmed.aau1167 10.1038/s41375-021-01390-3 10.1126/scitranslmed.aau5758 10.3390/cancers11122028 10.1038/s41571-021-00521-0 10.3390/genes9050243 10.1016/j.molmed.2019.06.009 10.1084/jem.20200924 10.1242/jcs.258399 10.3390/cells8080805 10.1126/sciadv.abg4000 10.1128/mSystems.00055-17 10.1126/sciadv.1600200 10.1038/s41586-021-03796-6 10.1158/1078-0432.CCR-20-4789 |
ContentType | Journal Article |
Copyright | The Author(s) 2022. corrected publication 2022 2022. The Author(s). The Author(s) 2022. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2022, corrected publication 2022 |
Copyright_xml | – notice: The Author(s) 2022. corrected publication 2022 – notice: 2022. The Author(s). – notice: The Author(s) 2022. corrected publication 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2022, corrected publication 2022 |
DBID | C6C CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7X7 7XB 88E 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABUWG AFKRA ARAPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P P5Z P62 P64 PIMPY PQEST PQQKQ PQUKI PRINS RC3 SOI 7X8 5PM DOA |
DOI | 10.1038/s41467-022-30223-9 |
DatabaseName | SpringerOpen Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Ecology Abstracts Entomology Abstracts (Full archive) Environment Abstracts Immunology Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Nucleic Acids Abstracts Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central Advanced Technologies & Aerospace Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database Advanced Technologies & Aerospace Database ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Publicly Available Content Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China Genetics Abstracts Environment Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Publicly Available Content Database ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management Health Research Premium Collection Natural Science Collection Biological Science Collection Chemoreception Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Medical Library (Alumni) Advanced Technologies & Aerospace Collection ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Entomology Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts Technology Collection Technology Research Database ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central Genetics Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) AIDS and Cancer Research Abstracts ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Immunology Abstracts Environment Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: C6C name: SpringerOpen url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: 8FG name: ProQuest Technology Collection url: https://search.proquest.com/technologycollection1 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2041-1723 |
EndPage | 2614 |
ExternalDocumentID | oai_doaj_org_article_80997f20894a4c6ab09d4081863d91de 10_1038_s41467_022_30223_9 35551192 |
Genre | Journal Article |
GrantInformation_xml | – fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) – fundername: Commonwealth Serum Laboratories Centenary Fellowship Australian Medical Research Future Fund Stem Cells Mission, grant 2008972 Beat Cancer Infrastructure Grant -IF1320 – fundername: Cancer Council South Australia grantid: 2002137; 2002137; 2002137 funderid: https://doi.org/10.13039/501100000950 – fundername: Royal Adelaide Hospital Contributing Haematologist's Committee - Grant Round 2015 – fundername: U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) grantid: P01HL131477-01A1; P01HL131477-01A1 funderid: https://doi.org/10.13039/100000050 – fundername: Department of Health | National Health and Medical Research Council (NHMRC) grantid: GNT1047129; GNT1047129; GNT1047129; 1182564; 1184485; GNT1047129 funderid: https://doi.org/10.13039/501100000925 – fundername: University of South Australia Postgraduate Award (USAPA) Singapore Ministry of Health's National Medical Research Council (Singapore Translational Research (STaR) Investigator Award STaR 18nov-0002 – fundername: Singapore Ministry of Health's National Medical Research Council (Singapore Translational Research (STaR) Investigator Award STaR 18nov-0002 – fundername: Hospital Research Foundation (The Hospital Research Foundation) grantid: C-PJ-173-Exper-2019 funderid: https://doi.org/10.13039/100009727 – fundername: Leukemia and Lymphoma Society (Leukemia & Lymphoma Society) – fundername: Department of Health | National Health and Medical Research Council (NHMRC) grantid: 1184485 – fundername: U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) grantid: P01HL131477-01A1 – fundername: Cancer Council South Australia grantid: 2002137 – fundername: Department of Health | National Health and Medical Research Council (NHMRC) grantid: 1182564 – fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) grantid: 1R01CA251331 – fundername: Hospital Research Foundation (The Hospital Research Foundation) grantid: C-PJ-173-Exper-2019 – fundername: Department of Health | National Health and Medical Research Council (NHMRC) grantid: GNT1047129 – fundername: Leukemia and Lymphoma Society (Leukemia & Lymphoma Society) grantid: 6619-21 – fundername: U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) grantid: R35CA197697 – fundername: ; – fundername: ; grantid: P01HL131477-01A1; P01HL131477-01A1 – fundername: ; grantid: C-PJ-173-Exper-2019 – fundername: ; grantid: 2002137; 2002137; 2002137 – fundername: ; grantid: GNT1047129; GNT1047129; GNT1047129; 1182564; 1184485; GNT1047129 – fundername: ; grantid: R35CA197697; R35CA197697; 1R01CA251331 – fundername: ; grantid: 6619-21; 6619-21 |
GroupedDBID | --- 0R~ 39C 3V. 53G 5VS 70F 7X7 88E 8AO 8FE 8FG 8FH 8FI 8FJ AAHBH AAJSJ ABUWG ACGFO ACGFS ACIWK ACMJI ACPRK ACSMW ADBBV ADFRT ADRAZ AENEX AFKRA AFRAH AHMBA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH AOIJS ARAPS ASPBG AVWKF AZFZN BBNVY BCNDV BENPR BGLVJ BHPHI BPHCQ BVXVI C6C CCPQU DIK EBLON EBS EE. EMOBN F5P FEDTE FYUFA GROUPED_DOAJ HCIFZ HMCUK HVGLF HYE HZ~ KQ8 LK8 M1P M48 M7P M~E NAO O9- OK1 P2P P62 PIMPY PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT SV3 TSG UKHRP CGR CUY CVF ECM EIF NPM AAYXX CITATION 7QL 7QP 7QR 7SN 7SS 7ST 7T5 7T7 7TM 7TO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. P64 PQEST PQUKI PRINS RC3 SOI 7X8 5PM |
ID | FETCH-LOGICAL-c540t-f6969da96b85b0e888f6524a103debf3e8348261cc9e61cd33e77d323f4c56593 |
IEDL.DBID | RPM |
ISSN | 2041-1723 |
IngestDate | Tue Dec 17 15:21:27 EST 2024 Tue Sep 17 21:16:38 EDT 2024 Sat Oct 05 06:06:26 EDT 2024 Thu Oct 10 19:46:15 EDT 2024 Thu Nov 21 23:11:10 EST 2024 Wed Oct 16 00:41:09 EDT 2024 Fri Oct 11 20:51:14 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | 2022. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c540t-f6969da96b85b0e888f6524a103debf3e8348261cc9e61cd33e77d323f4c56593 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0002-9527-2740 0000-0002-5814-0984 0000-0002-0837-1231 0000-0002-9023-0138 0000-0002-9619-0624 0000-0002-7361-9491 0000-0002-5135-6504 0000-0003-4606-7588 0000-0001-5072-0880 0000-0003-4322-2968 0000-0001-7172-3183 0000-0002-4915-4612 0000-0002-6482-2615 0000-0001-7154-744X 0000-0001-6690-5476 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098909/ |
PMID | 35551192 |
PQID | 2663135627 |
PQPubID | 546298 |
PageCount | 1 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_80997f20894a4c6ab09d4081863d91de pubmedcentral_primary_oai_pubmedcentral_nih_gov_9098909 proquest_miscellaneous_2664784014 proquest_journals_2663135627 crossref_primary_10_1038_s41467_022_30223_9 pubmed_primary_35551192 springer_journals_10_1038_s41467_022_30223_9 |
PublicationCentury | 2000 |
PublicationDate | 2022-05-12 |
PublicationDateYYYYMMDD | 2022-05-12 |
PublicationDate_xml | – month: 05 year: 2022 text: 2022-05-12 day: 12 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature communications |
PublicationTitleAbbrev | Nat Commun |
PublicationTitleAlternate | Nat Commun |
PublicationYear | 2022 |
Publisher | Nature Publishing Group UK Nature Publishing Group Nature Portfolio |
Publisher_xml | – sequence: 0 name: Nature Portfolio – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Garcia-Bermudez (CR7) 2018; 20 Clark, Yen, Mellinghoff (CR26) 2016; 22 Molenaar (CR69) 2017; 7 Yang (CR36) 2015; 12 Molenaar, Maciejewski, Wilmink, van Noorden (CR42) 2018; 37 Martínez-Reyes (CR3) 2020; 585 Larman (CR18) 2012; 109 Yu (CR51) 2020; 117 Son (CR54) 2013; 496 Tsuji, Akao, Masuya, Murai, Miyoshi (CR12) 2020; 295 Su (CR83) 2017; 33 DiNardo (CR75) 2018; 378 Lu (CR53) 2021; 11 Warburg, Wind, Negelein (CR1) 1927; 8 Birsoy (CR56) 2015; 162 CR76 Jones (CR72) 2018; 34 Ward (CR39) 2010; 17 CR73 Robinson, McCarthy, Smyth (CR80) 2010; 26 Twig, Hyde, Shirihai (CR33) 2008; 1777 CR70 Triska (CR20) 2019; 79 Cerchione (CR47) 2021; 11 Jumper (CR37) 2021; 596 Baccelli (CR10) 2019; 36 CR2 Stein (CR45) 2015; 28 Consortium (CR58) 2020; 578 Maung (CR22) 2018; 8 Chan (CR38) 2015; 21 Stuani, Sarry (CR4) 2020; 32 (CR25) 2013; 368 CR41 CR40 Lun, Chen, Smyth (CR81) 2016; 1418 Yamashita, Dellorusso, Olson, Passegué (CR61) 2020; 20 Lee, Mukha, Aizenshtein, Shlomi (CR15) 2019; 10 Choe (CR74) 2020; 4 Wu, Akhtari, Alachkar (CR21) 2018; 8 Subramanian (CR84) 2005; 102 Gelman (CR49) 2018; 22 Huang, Wang, Xu, Peng (CR57) 2020; 1873 McKeown (CR31) 2017; 7 Moschoi (CR71) 2016; 128 Wang (CR46) 2013; 340 Corces-Zimmerman, Hong, Weissman, Medeiros, Majeti (CR30) 2014; 111 Chen (CR48) 2019; 1 CR17 CR16 CR59 CR14 Thorvaldsdottir, Robinson, Mesirov (CR82) 2013; 14 DiNardo (CR8) 2020; 135 Sharma (CR19) 2011; 20 CR52 Jayasinghe, Mendis, Roessner, Dias (CR78) 2018; 1778 Leiserson, Reyna, Raphael (CR85) 2016; 32 van Gastel (CR9) 2020; 32 Molina (CR11) 2018; 24 Jan (CR28) 2012; 4 Grassian (CR34) 2014; 74 Guo, Zong, Wu, Gu, Yang (CR35) 2017; 170 Roboz (CR43) 2020; 135 Dias (CR77) 2015; 1000 Leif (CR23) 1993; 21 Tiong, Wei (CR44) 2019; 58 Schimmer (CR13) 2017; 7 CR29 CR27 Tyner (CR79) 2018; 562 CR24 CR68 CR67 CR66 CR65 Tang (CR50) 2020; 19 Iwasaki, Liedtke, Gentles, Cleary (CR64) 2015; 17 Balsa (CR55) 2020; 11 CR63 CR62 Sullivan (CR6) 2018; 20 CR60 Jenuth, Peterson, Shoubridge (CR32) 1997; 16 Sullivan (CR5) 2015; 162 I Martínez-Reyes (30223_CR3) 2020; 585 MD Leiserson (30223_CR85) 2016; 32 DA Dias (30223_CR77) 2015; 1000 C Cerchione (30223_CR47) 2021; 11 PS Ward (30223_CR39) 2010; 17 N van Gastel (30223_CR9) 2020; 32 JW Tyner (30223_CR79) 2018; 562 ITP-CAoWG Consortium (30223_CR58) 2020; 578 CL Jones (30223_CR72) 2018; 34 AT Lun (30223_CR81) 2016; 1418 O Warburg (30223_CR1) 1927; 8 J Garcia-Bermudez (30223_CR7) 2018; 20 WD Lee (30223_CR15) 2019; 10 J Son (30223_CR54) 2013; 496 30223_CR40 RJ Molenaar (30223_CR69) 2017; 7 30223_CR41 J Jumper (30223_CR37) 2021; 596 MD Robinson (30223_CR80) 2010; 26 S Wu (30223_CR21) 2018; 8 TC Larman (30223_CR18) 2012; 109 R Guo (30223_CR35) 2017; 170 X Tang (30223_CR50) 2020; 19 Cancer Genome Atlas Research, N. (30223_CR25) 2013; 368 AD Schimmer (30223_CR13) 2017; 7 EM Stein (30223_CR45) 2015; 28 X Lu (30223_CR53) 2021; 11 L Stuani (30223_CR4) 2020; 32 H Leif (30223_CR23) 1993; 21 30223_CR14 H Thorvaldsdottir (30223_CR82) 2013; 14 CD DiNardo (30223_CR75) 2018; 378 30223_CR17 AR Grassian (30223_CR34) 2014; 74 F Wang (30223_CR46) 2013; 340 30223_CR59 30223_CR16 P Triska (30223_CR20) 2019; 79 LB Sullivan (30223_CR5) 2015; 162 A Tsuji (30223_CR12) 2020; 295 30223_CR52 M Yamashita (30223_CR61) 2020; 20 LK Sharma (30223_CR19) 2011; 20 SJ Gelman (30223_CR49) 2018; 22 A Subramanian (30223_CR84) 2005; 102 30223_CR2 S Choe (30223_CR74) 2020; 4 MR Corces-Zimmerman (30223_CR30) 2014; 111 KZY Maung (30223_CR22) 2018; 8 R Moschoi (30223_CR71) 2016; 128 30223_CR24 MR McKeown (30223_CR31) 2017; 7 30223_CR68 LB Sullivan (30223_CR6) 2018; 20 30223_CR66 30223_CR67 30223_CR29 K Birsoy (30223_CR56) 2015; 162 30223_CR27 30223_CR60 JR Molina (30223_CR11) 2018; 24 30223_CR65 I Baccelli (30223_CR10) 2019; 36 30223_CR62 M Iwasaki (30223_CR64) 2015; 17 30223_CR63 L Chen (30223_CR48) 2019; 1 J Yang (30223_CR36) 2015; 12 G Twig (30223_CR33) 2008; 1777 IS Tiong (30223_CR44) 2019; 58 GJ Roboz (30223_CR43) 2020; 135 D Yu (30223_CR51) 2020; 117 S Su (30223_CR83) 2017; 33 NS Jayasinghe (30223_CR78) 2018; 1778 E Balsa (30223_CR55) 2020; 11 L Huang (30223_CR57) 2020; 1873 RJ Molenaar (30223_CR42) 2018; 37 SM Chan (30223_CR38) 2015; 21 O Clark (30223_CR26) 2016; 22 JP Jenuth (30223_CR32) 1997; 16 CD DiNardo (30223_CR8) 2020; 135 30223_CR70 30223_CR76 M Jan (30223_CR28) 2012; 4 30223_CR73 |
References_xml | – ident: CR70 – volume: 1000 start-page: 1 year: 2015 end-page: 13 ident: CR77 article-title: Quantitative profiling of polar primary metabolites of two chickpea cultivars with contrasting responses to salinity publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2015.07.002 contributor: fullname: Dias – volume: 11 start-page: 686765 year: 2021 ident: CR53 article-title: The combined treatment with the FLT3-inhibitor AC220 and the complex I inhibitor IACS-010759 synergistically depletes Wt- and FLT3-mutated acute myeloid leukemia cells publication-title: Front. Oncol. doi: 10.3389/fonc.2021.686765 contributor: fullname: Lu – ident: CR68 – volume: 135 start-page: 463 year: 2020 end-page: 471 ident: CR43 article-title: Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia publication-title: Blood doi: 10.1182/blood.2019002140 contributor: fullname: Roboz – volume: 111 start-page: 2548 year: 2014 end-page: 2553 ident: CR30 article-title: Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1324297111 contributor: fullname: Majeti – ident: CR16 – volume: 22 start-page: 512 year: 2018 end-page: 522 ident: CR49 article-title: Consumption of NADPH for 2-HG synthesis increases pentose phosphate pathway flux and sensitizes cells to oxidative Stress publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.12.050 contributor: fullname: Gelman – volume: 596 start-page: 583 year: 2021 end-page: 589 ident: CR37 article-title: Highly accurate protein structure prediction with AlphaFold publication-title: Nature doi: 10.1038/s41586-021-03819-2 contributor: fullname: Jumper – volume: 20 start-page: 775 year: 2018 end-page: 781 ident: CR7 article-title: Aspartate is a limiting metabolite for cancer cell proliferation under hypoxia and in tumours publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0118-z contributor: fullname: Garcia-Bermudez – volume: 8 year: 2018 ident: CR21 article-title: Characterization of mutations in the mitochondrial encoded electron transport chain complexes in acute myeloid leukemia publication-title: Sci. Rep. doi: 10.1038/s41598-018-31489-0 contributor: fullname: Alachkar – volume: 170 start-page: 1247 year: 2017 end-page: 1257 ident: CR35 article-title: Architecture of human mitochondrial respiratory megacomplex I2III2IV2 publication-title: Cell doi: 10.1016/j.cell.2017.07.050 contributor: fullname: Yang – volume: 12 start-page: 7 year: 2015 end-page: 8 ident: CR36 article-title: The I-TASSER Suite: protein structure and function prediction publication-title: Nat. Methods doi: 10.1038/nmeth.3213 contributor: fullname: Yang – volume: 295 start-page: 7481 year: 2020 end-page: 7491 ident: CR12 article-title: IACS-010759, a potent inhibitor of glycolysis-deficient hypoxic tumor cells, inhibits mitochondrial respiratory complex I through a unique mechanism publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA120.013366 contributor: fullname: Miyoshi – volume: 8 start-page: 519 year: 1927 end-page: 530 ident: CR1 article-title: The metabolism of tumors in the body publication-title: J. Gen. Physiol. doi: 10.1085/jgp.8.6.519 contributor: fullname: Negelein – volume: 32 start-page: 321 year: 2020 end-page: 323 ident: CR4 article-title: Microenvironmental aspartate preserves leukemic cells from therapy-induced metabolic collapse publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.08.008 contributor: fullname: Sarry – volume: 58 start-page: 903 year: 2019 end-page: 914 ident: CR44 article-title: New drugs creating new challenges in acute myeloid leukemia publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.22750 contributor: fullname: Wei – volume: 34 start-page: 724 year: 2018 end-page: 740 ident: CR72 article-title: Inhibition of amino acid metabolism selectively targets human leukemia stem cells publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.10.005 contributor: fullname: Jones – ident: CR29 – volume: 1873 start-page: 188332 year: 2020 ident: CR57 article-title: Targeting citrate as a novel therapeutic strategy in cancer treatment publication-title: Biochim. Biophys. Acta Rev. Cancer doi: 10.1016/j.bbcan.2019.188332 contributor: fullname: Peng – volume: 1 start-page: 404 year: 2019 end-page: 415 ident: CR48 article-title: NADPH production by the oxidative pentose-phosphate pathway supports folate metabolism publication-title: Nat. Metab. doi: 10.1038/s42255-019-0043-x contributor: fullname: Chen – volume: 16 start-page: 93 year: 1997 end-page: 95 ident: CR32 article-title: Tissue-specific selection for different mtDNA genotypes in heteroplasmic mice publication-title: Nat. Genet. doi: 10.1038/ng0597-93 contributor: fullname: Shoubridge – volume: 28 start-page: 112 year: 2015 end-page: 115 ident: CR45 article-title: IDH2 inhibition in AML: finally progress? publication-title: Best Pract. Res. Clin. Haematol. doi: 10.1016/j.beha.2015.10.016 contributor: fullname: Stein – volume: 562 start-page: 526 year: 2018 end-page: 531 ident: CR79 article-title: Functional genomic landscape of acute myeloid leukaemia publication-title: Nature doi: 10.1038/s41586-018-0623-z contributor: fullname: Tyner – volume: 102 start-page: 15545 year: 2005 end-page: 15550 ident: CR84 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0506580102 contributor: fullname: Subramanian – volume: 162 start-page: 540 year: 2015 end-page: 551 ident: CR56 article-title: An essential role of the mitochondrial electron transport chain in cell proliferation is to enable aspartate synthesis publication-title: Cell doi: 10.1016/j.cell.2015.07.016 contributor: fullname: Birsoy – volume: 11 start-page: 639387 year: 2021 ident: CR47 article-title: IDH1/IDH2 inhibition in acute myeloid leukemia publication-title: Front. Oncol. doi: 10.3389/fonc.2021.639387 contributor: fullname: Cerchione – ident: CR67 – volume: 340 start-page: 622 year: 2013 end-page: 626 ident: CR46 article-title: Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation publication-title: Science doi: 10.1126/science.1234769 contributor: fullname: Wang – volume: 135 start-page: 791 year: 2020 end-page: 803 ident: CR8 article-title: Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML publication-title: Blood doi: 10.1182/blood.2019003988 contributor: fullname: DiNardo – volume: 8 year: 2018 ident: CR22 article-title: Rare variants in Fanconi anemia genes are enriched in acute myeloid leukemia publication-title: Blood Cancer J. doi: 10.1038/s41408-018-0090-7 contributor: fullname: Maung – volume: 4 start-page: 1894 year: 2020 end-page: 1905 ident: CR74 article-title: Molecular mechanisms mediating relapse following ivosidenib monotherapy in IDH1-mutant relapsed or refractory AML publication-title: Blood Adv. doi: 10.1182/bloodadvances.2020001503 contributor: fullname: Choe – ident: CR60 – volume: 37 start-page: 1949 year: 2018 end-page: 1960 ident: CR42 article-title: Wild-type and mutated IDH1/2 enzymes and therapy responses publication-title: Oncogene doi: 10.1038/s41388-017-0077-z contributor: fullname: van Noorden – volume: 14 start-page: 178 year: 2013 end-page: 192 ident: CR82 article-title: Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration publication-title: Brief Bioinform. doi: 10.1093/bib/bbs017 contributor: fullname: Mesirov – volume: 79 start-page: 1318 year: 2019 end-page: 1330 ident: CR20 article-title: Landscape of germline and somatic mitochondrial DNA mutations in pediatric malignancies publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-2220 contributor: fullname: Triska – volume: 26 start-page: 139 year: 2010 end-page: 140 ident: CR80 article-title: edgeR: a Bioconductor package for differential expression analysis of digital gene expression data publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 contributor: fullname: Smyth – volume: 11 year: 2020 ident: CR55 article-title: Defective NADPH production in mitochondrial disease complex I causes inflammation and cell death publication-title: Nat. Commun. doi: 10.1038/s41467-020-16423-1 contributor: fullname: Balsa – ident: CR66 – volume: 1778 start-page: 207 year: 2018 end-page: 223 ident: CR78 article-title: Quantification of sugars and organic acids in biological matrices using GC–QqQ–MS publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-7819-9_15 contributor: fullname: Dias – volume: 496 start-page: 101 year: 2013 end-page: 105 ident: CR54 article-title: Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway publication-title: Nature doi: 10.1038/nature12040 contributor: fullname: Son – volume: 19 start-page: 221 year: 2020 end-page: 230 ident: CR50 article-title: Blockade of glutathione metabolism in IDH1-mutated glioma publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-19-0103 contributor: fullname: Tang – ident: CR14 – ident: CR2 – volume: 368 start-page: 2059 year: 2013 end-page: 2074 ident: CR25 article-title: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1301689 – volume: 4 start-page: 149ra118 year: 2012 ident: CR28 article-title: Clonal evolution of preleukemic hematopoietic stem cells precedes human acute myeloid leukemia publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3004315 contributor: fullname: Jan – volume: 578 start-page: 82 year: 2020 end-page: 93 ident: CR58 article-title: Pan-cancer analysis of whole genomes publication-title: Nature doi: 10.1038/s41586-020-1969-6 contributor: fullname: Consortium – volume: 1777 start-page: 1092 year: 2008 end-page: 1097 ident: CR33 article-title: Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbabio.2008.05.001 contributor: fullname: Shirihai – volume: 24 start-page: 1036 year: 2018 end-page: 1046 ident: CR11 article-title: An inhibitor of oxidative phosphorylation exploits cancer vulnerability publication-title: Nat. Med. doi: 10.1038/s41591-018-0052-4 contributor: fullname: Molina – volume: 17 start-page: 225 year: 2010 end-page: 234 ident: CR39 article-title: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.01.020 contributor: fullname: Ward – volume: 20 start-page: 365 year: 2020 end-page: 382 ident: CR61 article-title: Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0260-3 contributor: fullname: Passegué – volume: 1418 start-page: 391 year: 2016 end-page: 416 ident: CR81 article-title: It’s DE-licious: A Recipe for Differential Expression Analyses of RNA-seq Experiments Using Quasi-Likelihood Methods in edgeR publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-3578-9_19 contributor: fullname: Smyth – volume: 21 start-page: 998 year: 1993 end-page: 1001 ident: CR23 article-title: Escherichia coli NADH dehydrogenase I, a minimal form of the mitochondrial complex I publication-title: Biochem. Soc. Trans. doi: 10.1042/bst0210998 contributor: fullname: Leif – volume: 33 start-page: 2050 year: 2017 end-page: 2052 ident: CR83 article-title: Glimma: interactive graphics for gene expression analysis publication-title: Bioinformatics doi: 10.1093/bioinformatics/btx094 contributor: fullname: Su – volume: 32 start-page: i736 year: 2016 end-page: i745 ident: CR85 article-title: A weighted exact test for mutually exclusive mutations in cancer publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw462 contributor: fullname: Raphael – volume: 22 start-page: 1837 year: 2016 end-page: 1842 ident: CR26 article-title: Molecular pathways: isocitrate dehydrogenase mutations in cancer publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-1333 contributor: fullname: Mellinghoff – volume: 17 start-page: 412 year: 2015 end-page: 421 ident: CR64 article-title: CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-rearranged acute myeloid leukemia publication-title: Cell Stem Cell doi: 10.1016/j.stem.2015.08.008 contributor: fullname: Cleary – ident: CR40 – ident: CR63 – volume: 20 start-page: 782 year: 2018 end-page: 788 ident: CR6 article-title: Aspartate is an endogenous metabolic limitation for tumour growth publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0125-0 contributor: fullname: Sullivan – ident: CR27 – volume: 378 start-page: 2386 year: 2018 end-page: 2398 ident: CR75 article-title: Durable remissions with ivosidenib in IDH1-mutated relapsed or refractory AML publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1716984 contributor: fullname: DiNardo – volume: 20 start-page: 4605 year: 2011 end-page: 4616 ident: CR19 article-title: Mitochondrial respiratory complex I dysfunction promotes tumorigenesis through ROS alteration and AKT activation publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddr395 contributor: fullname: Sharma – volume: 162 start-page: 552 year: 2015 end-page: 563 ident: CR5 article-title: Supporting aspartate biosynthesis is an essential function of respiration in proliferating cells publication-title: Cell doi: 10.1016/j.cell.2015.07.017 contributor: fullname: Sullivan – volume: 10 year: 2019 ident: CR15 article-title: Spatial-fluxomics provides a subcellular-compartmentalized view of reductive glutamine metabolism in cancer cells publication-title: Nat. Commun. doi: 10.1038/s41467-019-09352-1 contributor: fullname: Shlomi – ident: CR73 – ident: CR65 – volume: 109 start-page: 14087 year: 2012 end-page: 14091 ident: CR18 article-title: Spectrum of somatic mitochondrial mutations in five cancers publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1211502109 contributor: fullname: Larman – volume: 128 start-page: 253 year: 2016 end-page: 264 ident: CR71 article-title: Protective mitochondrial transfer from bone marrow stromal cells to acute myeloid leukemic cells during chemotherapy publication-title: Blood doi: 10.1182/blood-2015-07-655860 contributor: fullname: Moschoi – volume: 585 start-page: 288 year: 2020 end-page: 292 ident: CR3 article-title: Mitochondrial ubiquinol oxidation is necessary for tumour growth publication-title: Nature doi: 10.1038/s41586-020-2475-6 contributor: fullname: Martínez-Reyes – ident: CR52 – ident: CR17 – volume: 36 start-page: 84 year: 2019 end-page: 99e88 ident: CR10 article-title: Mubritinib targets the electron transport chain complex I and reveals the landscape of OXPHOS dependency in acute myeloid leukemia publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.06.003 contributor: fullname: Baccelli – volume: 7 start-page: e014961 year: 2017 ident: CR69 article-title: Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1-mutated or IDH2-mutated solid tumours publication-title: BMJ Open doi: 10.1136/bmjopen-2016-014961 contributor: fullname: Molenaar – volume: 7 start-page: 670 year: 2017 end-page: 672 ident: CR13 article-title: Novel mitochondrial mechanisms of cytarabine resistance in primary AML cells publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-17-0476 contributor: fullname: Schimmer – volume: 74 start-page: 3317 year: 2014 end-page: 3331 ident: CR34 article-title: IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-0772-T contributor: fullname: Grassian – ident: CR59 – ident: CR76 – volume: 7 start-page: 1136 year: 2017 end-page: 1153 ident: CR31 article-title: Superenhancer analysis defines novel epigenomic subtypes of non-APL AML, including an RARalpha dependency targetable by SY-1425, a potent and selective RARalpha agonist publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-17-0399 contributor: fullname: McKeown – ident: CR41 – ident: CR62 – volume: 117 start-page: 9964 year: 2020 end-page: 9972 ident: CR51 article-title: Triptolide suppresses IDH1-mutated malignancy via Nrf2-driven glutathione metabolism publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1913633117 contributor: fullname: Yu – ident: CR24 – volume: 21 start-page: 178 year: 2015 end-page: 184 ident: CR38 article-title: Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia publication-title: Nat. Med. doi: 10.1038/nm.3788 contributor: fullname: Chan – volume: 32 start-page: 391 year: 2020 end-page: 403 ident: CR9 article-title: Induction of a timed metabolic collapse to overcome cancer chemoresistance publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.07.009 contributor: fullname: van Gastel – volume: 22 start-page: 512 year: 2018 ident: 30223_CR49 publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.12.050 contributor: fullname: SJ Gelman – volume: 162 start-page: 540 year: 2015 ident: 30223_CR56 publication-title: Cell doi: 10.1016/j.cell.2015.07.016 contributor: fullname: K Birsoy – ident: 30223_CR52 doi: 10.1096/fj.201800547R – volume: 17 start-page: 412 year: 2015 ident: 30223_CR64 publication-title: Cell Stem Cell doi: 10.1016/j.stem.2015.08.008 contributor: fullname: M Iwasaki – volume: 20 start-page: 782 year: 2018 ident: 30223_CR6 publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0125-0 contributor: fullname: LB Sullivan – ident: 30223_CR14 doi: 10.1038/s41375-021-01416-w – ident: 30223_CR68 doi: 10.1126/scitranslmed.aav0936 – ident: 30223_CR70 doi: 10.1182/bloodadvances.2020003661 – volume: 596 start-page: 583 year: 2021 ident: 30223_CR37 publication-title: Nature doi: 10.1038/s41586-021-03819-2 contributor: fullname: J Jumper – volume: 22 start-page: 1837 year: 2016 ident: 30223_CR26 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-13-1333 contributor: fullname: O Clark – volume: 1777 start-page: 1092 year: 2008 ident: 30223_CR33 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbabio.2008.05.001 contributor: fullname: G Twig – ident: 30223_CR60 doi: 10.1038/s41588-021-00868-1 – volume: 1418 start-page: 391 year: 2016 ident: 30223_CR81 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-3578-9_19 contributor: fullname: AT Lun – volume: 135 start-page: 791 year: 2020 ident: 30223_CR8 publication-title: Blood doi: 10.1182/blood.2019003988 contributor: fullname: CD DiNardo – volume: 10 year: 2019 ident: 30223_CR15 publication-title: Nat. Commun. doi: 10.1038/s41467-019-09352-1 contributor: fullname: WD Lee – volume: 11 start-page: 639387 year: 2021 ident: 30223_CR47 publication-title: Front. Oncol. doi: 10.3389/fonc.2021.639387 contributor: fullname: C Cerchione – volume: 585 start-page: 288 year: 2020 ident: 30223_CR3 publication-title: Nature doi: 10.1038/s41586-020-2475-6 contributor: fullname: I Martínez-Reyes – ident: 30223_CR29 doi: 10.7554/eLife.45105 – volume: 7 start-page: 1136 year: 2017 ident: 30223_CR31 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-17-0399 contributor: fullname: MR McKeown – ident: 30223_CR67 doi: 10.1126/scitranslmed.aau1167 – ident: 30223_CR63 doi: 10.1038/s41375-021-01390-3 – volume: 7 start-page: 670 year: 2017 ident: 30223_CR13 publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-17-0476 contributor: fullname: AD Schimmer – volume: 7 start-page: e014961 year: 2017 ident: 30223_CR69 publication-title: BMJ Open doi: 10.1136/bmjopen-2016-014961 contributor: fullname: RJ Molenaar – ident: 30223_CR73 doi: 10.1126/scitranslmed.aau5758 – volume: 19 start-page: 221 year: 2020 ident: 30223_CR50 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-19-0103 contributor: fullname: X Tang – volume: 8 year: 2018 ident: 30223_CR21 publication-title: Sci. Rep. doi: 10.1038/s41598-018-31489-0 contributor: fullname: S Wu – volume: 16 start-page: 93 year: 1997 ident: 30223_CR32 publication-title: Nat. Genet. doi: 10.1038/ng0597-93 contributor: fullname: JP Jenuth – volume: 378 start-page: 2386 year: 2018 ident: 30223_CR75 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1716984 contributor: fullname: CD DiNardo – ident: 30223_CR41 doi: 10.3390/cancers11122028 – volume: 340 start-page: 622 year: 2013 ident: 30223_CR46 publication-title: Science doi: 10.1126/science.1234769 contributor: fullname: F Wang – volume: 11 start-page: 686765 year: 2021 ident: 30223_CR53 publication-title: Front. Oncol. doi: 10.3389/fonc.2021.686765 contributor: fullname: X Lu – volume: 21 start-page: 998 year: 1993 ident: 30223_CR23 publication-title: Biochem. Soc. Trans. doi: 10.1042/bst0210998 contributor: fullname: H Leif – volume: 170 start-page: 1247 year: 2017 ident: 30223_CR35 publication-title: Cell doi: 10.1016/j.cell.2017.07.050 contributor: fullname: R Guo – volume: 1778 start-page: 207 year: 2018 ident: 30223_CR78 publication-title: Methods Mol. Biol. doi: 10.1007/978-1-4939-7819-9_15 contributor: fullname: NS Jayasinghe – volume: 58 start-page: 903 year: 2019 ident: 30223_CR44 publication-title: Genes Chromosomes Cancer doi: 10.1002/gcc.22750 contributor: fullname: IS Tiong – volume: 21 start-page: 178 year: 2015 ident: 30223_CR38 publication-title: Nat. Med. doi: 10.1038/nm.3788 contributor: fullname: SM Chan – volume: 4 start-page: 1894 year: 2020 ident: 30223_CR74 publication-title: Blood Adv. doi: 10.1182/bloodadvances.2020001503 contributor: fullname: S Choe – ident: 30223_CR27 doi: 10.1038/s41571-021-00521-0 – volume: 20 start-page: 4605 year: 2011 ident: 30223_CR19 publication-title: Hum. Mol. Genet. doi: 10.1093/hmg/ddr395 contributor: fullname: LK Sharma – ident: 30223_CR24 doi: 10.3390/genes9050243 – ident: 30223_CR2 doi: 10.1016/j.molmed.2019.06.009 – volume: 368 start-page: 2059 year: 2013 ident: 30223_CR25 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1301689 contributor: fullname: Cancer Genome Atlas Research, N. – volume: 28 start-page: 112 year: 2015 ident: 30223_CR45 publication-title: Best Pract. Res. Clin. Haematol. doi: 10.1016/j.beha.2015.10.016 contributor: fullname: EM Stein – ident: 30223_CR40 doi: 10.1084/jem.20200924 – volume: 128 start-page: 253 year: 2016 ident: 30223_CR71 publication-title: Blood doi: 10.1182/blood-2015-07-655860 contributor: fullname: R Moschoi – volume: 109 start-page: 14087 year: 2012 ident: 30223_CR18 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1211502109 contributor: fullname: TC Larman – volume: 11 year: 2020 ident: 30223_CR55 publication-title: Nat. Commun. doi: 10.1038/s41467-020-16423-1 contributor: fullname: E Balsa – volume: 26 start-page: 139 year: 2010 ident: 30223_CR80 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btp616 contributor: fullname: MD Robinson – volume: 8 start-page: 519 year: 1927 ident: 30223_CR1 publication-title: J. Gen. Physiol. doi: 10.1085/jgp.8.6.519 contributor: fullname: O Warburg – volume: 4 start-page: 149ra118 year: 2012 ident: 30223_CR28 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3004315 contributor: fullname: M Jan – volume: 135 start-page: 463 year: 2020 ident: 30223_CR43 publication-title: Blood doi: 10.1182/blood.2019002140 contributor: fullname: GJ Roboz – ident: 30223_CR59 doi: 10.1242/jcs.258399 – volume: 20 start-page: 775 year: 2018 ident: 30223_CR7 publication-title: Nat. Cell Biol. doi: 10.1038/s41556-018-0118-z contributor: fullname: J Garcia-Bermudez – ident: 30223_CR16 doi: 10.3390/cells8080805 – volume: 12 start-page: 7 year: 2015 ident: 30223_CR36 publication-title: Nat. Methods doi: 10.1038/nmeth.3213 contributor: fullname: J Yang – ident: 30223_CR65 doi: 10.1126/sciadv.abg4000 – volume: 14 start-page: 178 year: 2013 ident: 30223_CR82 publication-title: Brief Bioinform. doi: 10.1093/bib/bbs017 contributor: fullname: H Thorvaldsdottir – volume: 37 start-page: 1949 year: 2018 ident: 30223_CR42 publication-title: Oncogene doi: 10.1038/s41388-017-0077-z contributor: fullname: RJ Molenaar – volume: 295 start-page: 7481 year: 2020 ident: 30223_CR12 publication-title: J. Biol. Chem. doi: 10.1074/jbc.RA120.013366 contributor: fullname: A Tsuji – ident: 30223_CR76 doi: 10.1128/mSystems.00055-17 – volume: 562 start-page: 526 year: 2018 ident: 30223_CR79 publication-title: Nature doi: 10.1038/s41586-018-0623-z contributor: fullname: JW Tyner – volume: 33 start-page: 2050 year: 2017 ident: 30223_CR83 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btx094 contributor: fullname: S Su – volume: 496 start-page: 101 year: 2013 ident: 30223_CR54 publication-title: Nature doi: 10.1038/nature12040 contributor: fullname: J Son – volume: 8 year: 2018 ident: 30223_CR22 publication-title: Blood Cancer J. doi: 10.1038/s41408-018-0090-7 contributor: fullname: KZY Maung – ident: 30223_CR62 doi: 10.1126/sciadv.1600200 – volume: 578 start-page: 82 year: 2020 ident: 30223_CR58 publication-title: Nature doi: 10.1038/s41586-020-1969-6 contributor: fullname: ITP-CAoWG Consortium – volume: 1873 start-page: 188332 year: 2020 ident: 30223_CR57 publication-title: Biochim. Biophys. Acta Rev. Cancer doi: 10.1016/j.bbcan.2019.188332 contributor: fullname: L Huang – volume: 20 start-page: 365 year: 2020 ident: 30223_CR61 publication-title: Nat. Rev. Cancer doi: 10.1038/s41568-020-0260-3 contributor: fullname: M Yamashita – volume: 24 start-page: 1036 year: 2018 ident: 30223_CR11 publication-title: Nat. Med. doi: 10.1038/s41591-018-0052-4 contributor: fullname: JR Molina – volume: 34 start-page: 724 year: 2018 ident: 30223_CR72 publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.10.005 contributor: fullname: CL Jones – volume: 74 start-page: 3317 year: 2014 ident: 30223_CR34 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-14-0772-T contributor: fullname: AR Grassian – ident: 30223_CR17 doi: 10.1038/s41586-021-03796-6 – volume: 32 start-page: i736 year: 2016 ident: 30223_CR85 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btw462 contributor: fullname: MD Leiserson – volume: 111 start-page: 2548 year: 2014 ident: 30223_CR30 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1324297111 contributor: fullname: MR Corces-Zimmerman – volume: 1 start-page: 404 year: 2019 ident: 30223_CR48 publication-title: Nat. Metab. doi: 10.1038/s42255-019-0043-x contributor: fullname: L Chen – volume: 1000 start-page: 1 year: 2015 ident: 30223_CR77 publication-title: J. Chromatogr. B Anal. Technol. Biomed. Life Sci. doi: 10.1016/j.jchromb.2015.07.002 contributor: fullname: DA Dias – volume: 32 start-page: 321 year: 2020 ident: 30223_CR4 publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.08.008 contributor: fullname: L Stuani – ident: 30223_CR66 doi: 10.1158/1078-0432.CCR-20-4789 – volume: 102 start-page: 15545 year: 2005 ident: 30223_CR84 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0506580102 contributor: fullname: A Subramanian – volume: 36 start-page: 84 year: 2019 ident: 30223_CR10 publication-title: Cancer Cell doi: 10.1016/j.ccell.2019.06.003 contributor: fullname: I Baccelli – volume: 17 start-page: 225 year: 2010 ident: 30223_CR39 publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.01.020 contributor: fullname: PS Ward – volume: 32 start-page: 391 year: 2020 ident: 30223_CR9 publication-title: Cell Metab. doi: 10.1016/j.cmet.2020.07.009 contributor: fullname: N van Gastel – volume: 79 start-page: 1318 year: 2019 ident: 30223_CR20 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-18-2220 contributor: fullname: P Triska – volume: 162 start-page: 552 year: 2015 ident: 30223_CR5 publication-title: Cell doi: 10.1016/j.cell.2015.07.017 contributor: fullname: LB Sullivan – volume: 117 start-page: 9964 year: 2020 ident: 30223_CR51 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1913633117 contributor: fullname: D Yu |
SSID | ssj0000391844 |
Score | 2.49437 |
Snippet | The interaction of germline variation and somatic cancer driver mutations is under-investigated. Here we describe the genomic mitochondrial landscape in adult... Mitochondrial metabolism has been associated with tumourigenesis in acute myeloid leukaemia (AML) and currently considered as a potential therapeutic target.... |
SourceID | doaj pubmedcentral proquest crossref pubmed springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2614 |
SubjectTerms | 13/1 13/106 13/31 13/44 45/23 631/67/2327 631/67/68 692/4028/67/1990/283/1897 Acute myeloid leukemia Adult Citric acid Electron transport chain Epistasis Genomics Germ-Line Mutation Humanities and Social Sciences Humans Inhibitors Isocitrate dehydrogenase Isocitrate Dehydrogenase - genetics Leukemia Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Metabolism Mitochondria Mitochondrial DNA multidisciplinary Mutants Mutation NADH-ubiquinone oxidoreductase Science Science (multidisciplinary) Sensitivity Therapeutic targets |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQpUpcEG8CpTISN4ia2F7HPkJL2SLBiUq9WXY8ESt2vRWbVN0bP52xnV26PMSFQ3KwI8ea-Tye0Yw_E_ISd2w0-5qXzKL7JhzTpXMcSiY7z3QrYJJIkj5-ktNz8eFicnHjqq9YE5bpgbPgjlQ82tmxSmlhRSutq7QXiYeNe117SNa3YjeCqWSDucbQRYynZCqujlYi2YRUvI4vXuqdnSgR9v_Jy_y9WPKXjGnaiE7vkjujB0nf5JnfI7cg3Cf7-U7J9QPy_T3a2ug70sWQ0-wrOgt0gSsXLV3wEXA0FZLDNT2jkcEJGxBG8TQjtcHTXBwej1TRq2EeWalTAe06DnN2Mq3LOHDoqW2HHv-yhvly5ukchq8WFjP7kJyfvvt8PC3HaxbKFt21vuykltpbLZ2auAowJO7khAmLYvPgOg4qEuDIum014NtzDk3jOeOdaNEd1PwR2QvLAE8Ilco5DYBRDkjhMZJrOuxnrGo63yjLC_JqI3Jzmdk0TMqCc2WyggzqxiQFGV2Qt1Er2y8jE3ZqQHyYER_mX_goyMFGp2ZcniuD8OQ1R9evKciLbTcurJgtsQGWQ_pGNBj-1qIgjzMEtjNBJy3mX1lBmh1w7Ex1tyfMviTybl1phU9BXm9g9HNafxfF0_8himfkNov4j9yz7IDs9d8GeI4uVe8O0-r5AbX-G_M priority: 102 providerName: Directory of Open Access Journals – databaseName: ProQuest Technology Collection dbid: 8FG link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELagCIkL4k1KQUbiBlET2-vHCfHabpHgRKXeLDt26IrdpHSTir3x05lxslstr0N8iC3H8Tw84xl_JuQFrNig9g3PmQPzTXhmcu95zJmsAzOViJMEkvTps5ydiI-nk9Nxw201plVudGJS1KGtcI_8EHrkJYfVWr0-_57jrVEYXR2v0LhObpRMSUzp09Oj7R4Lop9rIcazMgXXhyuRNENKYYeC52ZnPUqw_X-zNf9MmfwtbpqWo-kdcnu0I-mbgfB3ybXY3CM3h5sl1_fJzyPQuGhB0mU_BNtXdN7QJcgv6LsmINvRlE4ef9BjijhO8AKYCc80UtcEOqSI48EqetkvEJs6pdGusZvj97Myx46bjrqq7-Ar67ho54EuYv_NxeXcPSAn0w9f3s3y8bKFvAKjrctraaQJzkivJ76I4BjXcsKEg2kL0dc8aoTBkWVVmQhl4DwqFTjjtajAKDT8Idlr2iY-JlRq702M4OtEKQL4c6qGesYKVQelHc_Iy82U2_MBU8OmWDjXdiCQBdrYRCBrMvIWqbJtiXjY6UV78dWO4mU1HgCuWaGNcKKSzhcmiITWx4MpQ8zIwYamdhTSlb1iqYw831aDeGHMxDWx7VMbocAJLkVGHg0ssB0JmGoYhWUZUTvMsTPU3ZpmfpYgvE1hNDwZebVho6th_Xsq9v__F0_ILYacjdiy7IDsdRd9fAomU-efJbn4BXseFGA priority: 102 providerName: ProQuest – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwEB4ti5C4IN4EFmQkbhBobNeJDwjxWrpIy4lKe7PseLJUtCm0Cdre-OmMnaSoUDg0hzhN3XnY32hmPgM8oR2bln0tUm4JvknHdeqcwJSrynNdShxHkqTTT2oylR_PxmcHMBx31AtwvTe0C-dJTVfz5xffN6_I4V92LePFi7WM7h7r0ukiUn0JLnPaGUOJ12kP9-PKLDQFNLLvndn_1Z39KdL478Oef5dQ_pFHjdvT8XW41uNK9rozhBtwgPVNuNKdNLm5BT8_0AocECVbtF3yfc1mNVuQP5MIah_MkMXycrxgJyzwOtENMq7Q48hs7VlXMh4ardiPdh64qmNZ7Sa85uTdJEvDi-uG2bJt6Fc2OF_OPJtj-9XiYmZvw_T4_ee3k7Q_fCEtCcQ1aaW00t5q5YqxGyEFypUac2lJbB5dJbAItDgqK0uNdPVCYJ57wUUlSwKJWtyBw3pZ4z1gqnBOI1Lsg0p6iu_yisY5H-WVzwsrEng6iNx86zg2TMyNi8J0CjKkGxMVZHQCb4JWtk8Gfux4Y7k6N727mSI0BFd8VGhpZamsG2kvI3uf8DrzmMDRoFMz2JwhoxWZIECYJ_B4O0zuFnIotsZlG5-ROQXFmUzgbmcC25kQdAtZWZ5AvmMcO1PdHalnXyKltx7pgj4JPBvM6Pe0_i2K-___Fw_gKg-WHbhm-REcNqsWHxKEatyj6Be_ABDMF4w priority: 102 providerName: Scholars Portal – databaseName: SpringerOpen dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Nj9MwELVgERIXxDeBBRmJG0QktuvYRygsXSQ4sdLeLDueiGrbFNEE0Rs_nRknLQosBw7NIXZTy_PGfu7MvDD2HHdsXPatzIVH-qaCsHkIEnKhmyhsrWCWRJI-ftKLM_XhfHY-yuRQLcwkfi_Nq61KrpxyzvEic3uVXcM9uCI0z_X88H8KKZ0bpca6mMu_Otl7kkT_Zbzy7_TIP2Kkaes5ucVujpyRvx6MfJtdgfYOuz68RXJ3l_18j6srsUW-7ofA-pYvW75GX8W1rY0EMZ5Sx-EHP-Wk2YQ3EDhUv8h9G_mQDk5FVPx7vyId6pQyu6PHnL5dlDk9uO24r_sOf2UHq80y8hX0Fx7WS3-PnZ28-zxf5OOLFfIaCVqXN9pqG73VwcxCAXgIbvRMKI_TFiE0EgxJ3uiyri3gNUoJVRWlkI2qkQBaeZ8dtZsWHjKuTQgWAM81oFXEs1vVYLsQRdXEyniZsRf7KXdfB_0Ml-Le0rjBQA5t45KBnM3YG7LKoSdpX6cbCAk3upIzVOzbiMJY5VWtfShsVEmZT0ZbRsjY8d6mbnTIrUNAylIi2asy9uzQjK5E8RHfwqZPfVSFB95SZezBAIHDSJCWUcRVZKyagGMy1GlLu_yS5LptYQ1-MvZyD6Pfw_r3VDz6v-6P2Q1BSCddWXHMjrpvPTxButSFp8lPfgEIhw07 priority: 102 providerName: Springer Nature |
Title | Germline mutations in mitochondrial complex I reveal genetic and targetable vulnerability in IDH1-mutant acute myeloid leukaemia |
URI | https://link.springer.com/article/10.1038/s41467-022-30223-9 https://www.ncbi.nlm.nih.gov/pubmed/35551192 https://www.proquest.com/docview/2663135627 https://search.proquest.com/docview/2664784014 https://pubmed.ncbi.nlm.nih.gov/PMC9098909 https://doaj.org/article/80997f20894a4c6ab09d4081863d91de |
Volume | 13 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9tQ0i8IL4JjMpIvEHW1HYd-7Er67pKnSZg0t4iO3ZGRZtOa4PoG386ZycplI8XHupKdpRYvt_Zd7m7XwDe4ImN275iMdVovnFDVWwMczEVhaUq564fSJKm52J8ySdX_as96Le1MCFpPzezo3K-OCpnn0Nu5c0i77Z5Yt2L6VAlSuKvuw_7ePz-4qKH7Zcp9Fp4UyCTMNld8bAdhLx1bFjsqULxnPUhNLpzHgXa_r_Zmn-mTP4WNw3H0egB3G_sSDKo5_sQ9lz5CO7WX5bcPIbvp7jjeguSLKo62L4is5IsUH9xvyuthx0J6eTuGzkjnscJOxBMvqaR6NKSOkXcF1aRr9Xcc1OHNNqNv83Z-3Ev9jcu10Tn1RqfsnHz5cySuau-aLeY6SdwOTr5NBzHzccW4hyNtnVcCCWU1UoY2TeJQ8e4EH3KNa6gdaZgTnoaHNHLc-WwtYy5NLWMsoLnaBQq9hQOymXpngMR0hjlHPo6TnCL_lxa4DilSVrYVGoWwdt2ybObmlMjC7FwJrNaVhmKKQuyylQEx14q2ys9H3boWN5eZw0qMukLgAuaSMU1z4U2ibI8sPUxq3rWRXDYyjRrlHSVIUhZj6EBmEbwejuM6uVjJrp0yypcw1N0gns8gmc1BLYzaSEUQboDjp2p7o4gogOFd4PgCN61MPo5rX8vxYv_ftBLuEc9_j3tLD2Eg_Vt5V6hNbU2HdShqxRbOTrtwJ3BYPJxgv_HJ-cXH7B3KIad8J4C2ymXnaBrPwAz4CUR |
link.rule.ids | 230,314,727,780,784,864,885,2102,12056,12765,21388,24318,27924,27925,31719,31720,33373,33374,33744,33745,41120,42189,43310,43600,43805,51576,53791,53793,73745,74035,74302 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED9BJwQvE58jY4CReINoie0m8RNisNHCViG0SXuznNiBijYZa4LoG386d07aqXw9xA-x5Ti-D9_5zj8DPMcVG9W-EiE3aL7JnKswz4ULeVJargrphh4k6WSSjM7k-_Pheb_htujTKlc60StqWxe0R76PPYpY4Gqdvrr4FtKtURRd7a_QuA5bhJw-HMDWweHk46f1Lgvhn2dS9qdlIpHtL6TXDT6JHQsRqo0VyQP3_83a_DNp8rfIqV-Qjm7Ddm9Jstcd6e_ANVfdhRvd3ZLLe_DzHepcsiHZvO3C7Qs2rdgcJRg1XmWJ8ZhPKHc_2JgRkhO-QHaiU43MVJZ1SeJ0tIp9b2eETu0TaZfUzfjtKA6p46phpmgb_MrSzeqpZTPXfjVuPjX34ezo8PTNKOyvWwgLNNuasExUoqxRSZ4N88iha1wmQy4NTpt1eSlcRkA4SVwUymFphXBpagUXpSzQLFTiAQyqunIPgSVZnivn0NtxibTo0aUl1nMepaVNMyMCeLGacn3RoWpoHw0Xme4IpJE22hNIqwAOiCrrloSI7V_Ul591L2A6oyPAJY8yJY0sEpNHykqP1yesiq0LYG9FU92L6UJfMVUAz9bVKGAUNTGVq1vfRqboBscygJ2OBdYjQWON4rA8gHSDOTaGullTTb94EG8VqQyfAF6u2OhqWP-eit3__8VTuDk6PTnWx-PJh0dwixOXE9Is34NBc9m6x2hANfmTXkp-AT8EGLE |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lj9MwEB5BVyAuiDeBBYzEDaImtuvEJ8SyW1oe1Qqx0t4sJ3agok2WbYLojZ_O2HG7Kq9DfIgtx_E87Rl_BniGFhvVvmQx1ei-8YLKuCiYjamoDJUltyMPkvRhJiYn_O3p6DTkP61CWuVGJ3pFbZrS7ZEPsUeWMrTW2bAKaRHHh-OXZ99id4OUi7SG6zQuwx5axYQOYO_gaHb8cbvj4rDQc87DyZmE5cMV93rCJ7RjwWK5Y508iP_fPM8_Eyh_i6J64zS-AdeDV0le9WxwEy7Z-hZc6e-ZXN-Gn29Q_zp_kiy7PvS-IvOaLFGaUfvVxjEh8cnl9geZEofqhC-QtdwJR6JrQ_qEcXfMinzvFg6p2ifVrl0308NJGruO65bosmvxK2u7aOaGLGz3VdvlXN-Bk_HRp9eTOFy9EJfowrVxJaSQRktR5KMisbhMrsSIco3TZmxRMZs7UByRlqW0WBrGbJYZRlnFS3QRJbsLg7qp7X0gIi8KaS2ufKzgBld3WYX1lCZZZbJcswieb6ZcnfUIG8pHxlmuegIppI3yBFIyggNHlW1Lh47tXzTnn1UQNpW748AVTXLJNS-FLhJpuMfuY0amxkawv6GpCiK7UhcMFsHTbTUKm4ug6No2nW_DM1wSpzyCez0LbEeCjpuLydIIsh3m2Bnqbk09_-IBvWUic3wieLFho4th_XsqHvz_L57AVRQQ9X46e_cQrlHH5A50lu7DoD3v7CP0pdricRCSX2YwHN4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Germline+mutations+in+mitochondrial+complex+I+reveal+genetic+and+targetable+vulnerability+in+IDH1-mutant+acute+myeloid+leukaemia&rft.jtitle=Nature+communications&rft.au=Bassal%2C+Mahmoud+A&rft.au=Samaraweera%2C+Saumya+E&rft.au=Lim%2C+Kelly&rft.au=Benard%2C+Brooks+A&rft.date=2022-05-12&rft.pub=Nature+Publishing+Group&rft.eissn=2041-1723&rft.volume=13&rft.issue=1&rft_id=info:doi/10.1038%2Fs41467-022-30223-9&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2041-1723&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2041-1723&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2041-1723&client=summon |